Evidence map›Paper›PMID 38194031›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Establishing Single-Cell Clones from In Vitro-Cultured Circulating Tumor Cells.

Teng Teng, Min Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Teng TengDepartment of Stem Cell Biology and Regenerative Medicine, University of Southern California, Los Angeles, CA, USA.
Min YuDepartment of Stem Cell Biology and Regenerative Medicine, University of Southern California, Los Angeles, CA, USA. Min.Yu@som.umaryland.edu.
University of Southern California · US

Funding

Developing Individualized Medicine Targeting Metastatic Breast Cancer Stem CellsDP2CA206653 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YU, MIN · 2015 to 2019
$2.6M
Characterizing the role of TAK1 in breast cancer metastasisK22CA175228 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YU, MIN · 2014 to 2016
$592k
NCI NIH HHS DP2 CA206653NCI NIH HHS K22 CA175228
6 · The paper itself

Abstract

Cancer is a common health problem with more than 90% of deaths due to metastases. Circulating tumor cells (CTCs) contain precursors that can initiate metastases. However, CTCs are rare, heterogeneous, and difficult to expand in culture. We have previously created CTC-derived cell lines from stage IV breast cancer patients. These CTC lines were used to establish single-cell CTC clones using flow cytometry cell sorting.

Indexed as

Breast NeoplasmsNeoplastic Cells, CirculatingCell SeparationClone CellsFemaleFlow CytometryHumansBreast cancerCirculating tumor cellsCTC line cultureHeterogeneitySingle-cell clones

Identifiers

PMID38194031
OpenAlexW4390706449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.